Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| ADAP latest price $5.6700 (0.18%) ($5.6700 - $5.6700) on Mon. May. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.25% (three month average) | RSI | 67 | Latest Price | $5.6700(0.18%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ADAP advances 7.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) XAR(95%) UNG(64%) XLC(48%) SIL(93%) SLV(51%) | Factors Impacting ADAP price | ADAP will decline at least -2.125% in a week (0% probabilities). IWD(23%) LIT(-1%) IYT(20%) XRT(33%) IBB(76%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.125% (StdDev 4.25%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.7(-0.53%) | 10 Day Moving Average | $5.45(4.04%) | 20 Day Moving Average | $5.24(8.21%) | To recent high | -17.1% | To recent low | 12.8% | Market Cap | $877m | | | | Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |